Pluristem Therapeutics
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
PSTI Key Statistics
Stock Snapshot
With a market cap of 40.16M, Pluristem Therapeutics(PSTI) trades at $3.85. The stock has a price-to-earnings ratio of -0.60.
On 2026-10-26, Pluristem Therapeutics(PSTI) stock opened at —, reached a high of —, and a low of —.
Pluristem Therapeutics(PSTI) shares are trading with a volume of 0, against a daily average of 62K.
During the past year, Pluristem Therapeutics(PSTI) stock moved between $1.59 at its lowest and $5.68 at its peak.
During the past year, Pluristem Therapeutics(PSTI) stock moved between $1.59 at its lowest and $5.68 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.